IGF2BP2 and non-small cell lung carcinoma: Furthermore, IHC staining analysis indicated that the level of Ki67 was lower in IGF2BP2 knockdown crizotinib-resistant NSCLC tumor tissues compared with control tumor tissue, while tunel-positive cells were increased (Figure 6D).